Liothyronine (T3)
لیوتیرونین (T3)
🧬 Systemic Hormonal Preparations, Excl. Sex Hormones And InsulinsThyroid hormone
Market / country: 🇺🇸 USA
Cytomel (US)
🧮 Dose calculator
Hypothyroidism · Regimen source: FDA Liothyronine · 2.2
- • Increase by 25 mcg every 1–2 weeks by TSH. Elderly or cardiac patients: start 5 mcg. FDA Liothyronine · 2.2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Uncorrected adrenal insufficiency. FDA Liothyronine · 4
Warnings
- • Boxed warning: not for obesity or weight loss; large doses can cause serious or life-threatening toxicity. FDA Liothyronine · Boxed Warning
Formulations
- 5 mcg tablet — tablet 🇺🇸 USA FDA Liothyronine · 3
- 25 mcg tablet (scored) — tablet 🇺🇸 USA FDA Liothyronine · 3
- 50 mcg tablet (scored) — tablet 🇺🇸 USA FDA Liothyronine · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Liothyronine · 8.1
“Risk Summary Experience with liothyronine use in pregnant women, including data from post-marketing studies, have not reported increased rates of major birth defects or miscarriages (see Data).”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Liothyronine · 8.2
“Risk Summary Limited published studies report that liothyronine is present in human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Liothyronine · 8.4
“The initial dose of liothyronine sodium tablets varies with age and body weight.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Liothyronine · 8.5
“… ronine sodium tablets at less than the full replacement dose [see Dosage and Administration ( 2.3 ) and Warnings and Precautions ( 5.1 )] .”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA211510
- DailyMed (FDA label)FDA Liothyronine
- MedlinePlus (NIH)Liothyronine
- WHO ATC/DDDH03AA02
- Darooyab (Iran)❌ None
🇮🇷 Not found in Iran list Darooyab · search
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Liothyronine · 3FDA Liothyronine · 2.2FDA Liothyronine · 4FDA Liothyronine · Boxed WarningFDA Liothyronine · 8.1FDA Liothyronine · 8.2FDA Liothyronine · 8.4FDA Liothyronine · 8.5FDA Liothyronine · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · search
- Clinical review⚠ Unverified